An ALK5 inhibitor, vactosertib, can down-regulate the EMT markers (Vimentin, Snail, Slug, Twist) thus being considered as an option to prevent metastasis, when radiotherapy is applied to breast cancer patients (53). This evidence concerns the gene SNAI1 and breast cancer.